Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org
-- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Thursday, February 20, 2014
Wednesday, February 19, 2014
- Telling others about your MS may be the first thing you want to do—or the last.
In addition to what they do, Register with MS Views and News, to begin receiving OUR bi-monthly MS e-Newsletters that will help to keep you EMPOWERED with information. Register here
The ‘Hot Bath’ Test Used for Years to Diagnose MS
Heat-Related Symptoms are Temporary
Strategies for Easing the Effects of Heat
- Stay in an air-conditioned environment during periods of extreme heat and humidity. [If an air conditioner is needed to help minimize the symptoms of MS, the cost of this equipment may be tax deductible if the physician has written a prescription for it.]
- Use cooling products (vests, neck wraps, bandanas, etc.) during exercise or outdoor activity, or pre- and post-cool.
- Wear lightweight, loose, “breathe-able” clothing.
- Icy drinks such as “slurpees” or popsicles can provide temporary relief.
- Use an oscillating fan during indoor exercise.
- Exercise in a cool pool (<85 degrees).
- Given orally, as one or two courses per year, depending on the study regimen
- Although the parent company is not currently seeking approval, cladribine continues to be studied in RRMS
- Oral medication taken once daily; dosing is still under investigation
- Laquinimod is being studied in RRMS
Plegridy® PEGylated interferon beta-1a, also known as BIIB017)
- Administered by subcutaneous injection once every two weeks at a dose of 125 mcg (micrograms)
- Plegridy is being studied for relapsing forms of MS
Tuesday, February 18, 2014
|(2) TIPS to help you|
START NOW - CREATE YOUR REPORT
Watch this video: http://www.medpagetoday.com/HOTTOPICSWhatWorksWhatDoesnt/special-reports/SpecialReports-Videos/406
Monday, February 17, 2014
Share our Articles with others